top of page

POLTER

OPTIMIZATION OF BALIXAFORTIDE WITH NAB-PACLITAXEL OR ERIBULIN FOR HER2- ADVANCED BREAST CANCER

CLINICAL TRIAL DETAILS

OPTIMIZATION OF BALIXAFORTIDE WITH NAB-PACLITAXEL OR ERIBULIN FOR HER2- ADVANCED BREAST CANCER (POL6326 (BALIXAFORTIDE) PLUS NAB-PACLITAXEL OR ERIBULIN IN PATIENTS WITH HER2-NEGATIVE ADVANCED BREAST CANCER).

----

COUNTRY

STATUS

TUMOR TYPE

PHASE

N

SITES

BREAST

​

​

I, II

Spain

DRAFT

TRIAL OVERVIEW

home_fondo_you_barra.jpg

PRESS RELEASE

home_fondo_you_barra.jpg

-----

SCIENTIFIC IMPACT

home_fondo_you_barra.jpg

----

BLOG ARTICLES RELATED

home_fondo_you_barra.jpg

-----

TRIAL SITES

home_fondo_you_barra.jpg
----
Dr. Cortes and Dr. Llombart PHERain interview
Beyond Chemotherapy
Dr. Vanes Quiroga
Dr. Sofia Braga
Dr. Silvi Antolín
Dr. Escrivá de Romaní
Dr. Philipp Aftimos
Dr. Manuel Ruiz
Prof. Daniele Generali PHEGain interview
Dr. Jacques Medioni
Dr. Dunca Wheatley

TRIAL RESUME

home_fondo_you_barra.jpg
bottom of page